• Part time CFO
  • Transaction Services
  • Business Plan
  • Clients
  • About us
  • Blog
  • Contact Us
  • EN
    • FR

Eurekam, artificial intelligence for healthcare safety, raises €6.4 million

13 Oct, 2022
Transaction services: 2CFinance completed financial due diligence of Eurekam.

Eurekam, a company that develops solutions to control the processes of medication production, has raised €6.4 million from Impact Partners. The funds will be used to deploy Eurekam's technology globally and launch a solution dedicated to other hospital services. Eurekam was founded in 2012 by Loïc Tamarelle and Benoît Le France. The company has developed Drugcam, a technology that enables the secure composition of injectable drug preparations, particularly chemotherapy bags. Drugcam combines computer vision software and hardware to guide preparers during chemotherapy bag production, preventing toxic composition errors for patients.

Impact Partners is an investment fund that invests in innovative companies that have a positive impact on society. The fund has invested in numerous companies that are developing innovative solutions in healthcare, mobility, and the environment.

Eurekam's technology is an exciting development in the healthcare industry, as it ensures the safety of medication production for patients. The company's focus on chemotherapy bags is particularly important, as errors in the composition of chemotherapy medications can have serious consequences for patients. The company's solution, Drugcam, has the potential to significantly reduce these errors and improve patient outcomes. With the new funding, Eurekam can expand its reach and potentially save many more patient lives.

Impact Partners' investment in Eurekam is a testament to the company's potential to have a positive impact on society. The investment fund's focus on companies that are developing innovative solutions with positive societal impact is commendable and will hopefully encourage more investors to support companies that prioritize social responsibility.

Revenir à la page actualités
2CFinance Label B Corp

2CFinance est désormais certifiée B Corp

Par 2cfinance - 13 Oct 2022

2CFinance, entité de 2CGroup, devient au 16 avril 2025, Entreprise Certifiée B Corp . Qu’est-ce que la certification B Corp ? B Corp est un label indépendant et international, attribué par l’ONG B Lab. Il évalue les entreprises sur des critères rigoureux couvrant : Contrairement à une auto-déclaration ou un label produit, la certification repose […]

Read

Comment créer un Business Plan solide pour attirer les investisseurs ?

Par 2cfinance - 13 Oct 2022

Dans l’univers compétitif des start-ups et du capital-risque, la rédaction d’un business plan financier (BP) est d’une importance capitale, et ce bien avant les phases de due diligence. Ce document, loin d’être une simple formalité, doit être le fruit d’une réflexion stratégique minutieuse menée par les fondateurs. Pour optimiser les chances de réussite lors d’une […]

Read

Les apports du DAF Part Time dans le retournement d’entreprise

Par 2cfinance - 13 Oct 2022

Dans un environnement économique incertain, les start-ups et les PME peuvent se trouver confrontées à des crises de liquidité non anticipées ou à des difficultés financières. Face à ces situations, le recours aux Directeurs Administratifs et Financiers (DAF) part-time s’avère être une stratégie efficace pour anticiper les tensions de trésorerie, ajuster les prévisions et trouver […]

Read
+33 (0)1 45 80 10 64
20 Boulevard Montmartre, 75009 Paris
© 2025 - All rights reserved Legals 2CFinance recrute